Titre : Propanols

Propanols : Questions médicales fréquentes

Termes MeSH sélectionnés :

Polymorphism, Genetic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Propanols : Questions médicales les plus fréquentes", "headline": "Propanols : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Propanols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-24", "dateModified": "2025-03-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Propanols" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Alcools", "url": "https://questionsmedicales.fr/mesh/D000438", "about": { "@type": "MedicalCondition", "name": "Alcools", "code": { "@type": "MedicalCode", "code": "D000438", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.033" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Propan-1-ol", "alternateName": "1-Propanol", "url": "https://questionsmedicales.fr/mesh/D000433", "about": { "@type": "MedicalCondition", "name": "Propan-1-ol", "code": { "@type": "MedicalCode", "code": "D000433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.033.755.600" } } }, { "@type": "MedicalWebPage", "name": "Propan-2-ol", "alternateName": "2-Propanol", "url": "https://questionsmedicales.fr/mesh/D019840", "about": { "@type": "MedicalCondition", "name": "Propan-2-ol", "code": { "@type": "MedicalCode", "code": "D019840", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.033.755.615" } } } ], "about": { "@type": "MedicalCondition", "name": "Propanols", "alternateName": "Propanols", "code": { "@type": "MedicalCode", "code": "D020005", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fleming Martinez", "url": "https://questionsmedicales.fr/author/Fleming%20Martinez", "affiliation": { "@type": "Organization", "name": "Grupo de Investigaciones Farmacéutico-Fisicoquímicas, Departamento de Farmacia, Universidad Nacional de Colombia, Sede Bogotá, Cra. 30 No. 45-03, Bogotá D. C., Colombia." } }, { "@type": "Person", "name": "Elaheh Rahimpour", "url": "https://questionsmedicales.fr/author/Elaheh%20Rahimpour", "affiliation": { "@type": "Organization", "name": "Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, 5165665811, Iran." } }, { "@type": "Person", "name": "Abolghasem Jouyban", "url": "https://questionsmedicales.fr/author/Abolghasem%20Jouyban", "affiliation": { "@type": "Organization", "name": "Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, 5165665811, Iran." } }, { "@type": "Person", "name": "Ka-Young Park", "url": "https://questionsmedicales.fr/author/Ka-Young%20Park", "affiliation": { "@type": "Organization", "name": "Chemical Research Bureau, Occupational Safety and Health Research Institute, KOSHA, Daejeon 34122, Republic of Korea." } }, { "@type": "Person", "name": "Eun-Sang Cho", "url": "https://questionsmedicales.fr/author/Eun-Sang%20Cho", "affiliation": { "@type": "Organization", "name": "Chemical Research Bureau, Occupational Safety and Health Research Institute, KOSHA, Daejeon 34122, Republic of Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "HMOX1 genetic polymorphisms and outcomes in infectious disease: A systematic review.", "datePublished": "2022-05-12", "url": "https://questionsmedicales.fr/article/35551540", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0267399" } }, { "@type": "ScholarlyArticle", "name": "Genetic polymorphism of Y-chromosome in Kazakh populations from Southern Kazakhstan.", "datePublished": "2023-10-27", "url": "https://questionsmedicales.fr/article/37891458", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12864-023-09753-z" } }, { "@type": "ScholarlyArticle", "name": "Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic Polymorphisms.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36338339", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/5748924" } }, { "@type": "ScholarlyArticle", "name": "The Analysis of Genetic Polymorphism on Mitochondrial Hypervariable Region III in Thai Population.", "datePublished": "2023-03-09", "url": "https://questionsmedicales.fr/article/36980954", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/genes14030682" } }, { "@type": "ScholarlyArticle", "name": "Investigating genetic polymorphism in E. histolytica isolates with distinct clinical phenotypes.", "datePublished": "2023-08-29", "url": "https://questionsmedicales.fr/article/37642770", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00436-023-07952-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Alcools", "item": "https://questionsmedicales.fr/mesh/D000438" }, { "@type": "ListItem", "position": 4, "name": "Propanols", "item": "https://questionsmedicales.fr/mesh/D020005" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Propanols - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Propanols", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Propanols", "description": "Comment diagnostiquer une intoxication au propanol ?\nQuels tests sont utilisés pour évaluer l'exposition au propanol ?\nQuels symptômes indiquent une intoxication au propanol ?\nY a-t-il des marqueurs biologiques pour le propanol ?\nComment différencier le propanol des autres alcools ?", "url": "https://questionsmedicales.fr/mesh/D020005?mesh_terms=Polymorphism,+Genetic&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Propanols", "description": "Quels sont les symptômes d'une exposition au propanol ?\nL'exposition au propanol peut-elle causer des troubles neurologiques ?\nQuels effets à long terme peut avoir le propanol ?\nLes symptômes varient-ils selon la voie d'exposition ?\nPeut-on développer une allergie au propanol ?", "url": "https://questionsmedicales.fr/mesh/D020005?mesh_terms=Polymorphism,+Genetic&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Propanols", "description": "Comment prévenir l'exposition au propanol ?\nQuelles sont les mesures de sécurité lors de la manipulation du propanol ?\nLes enfants peuvent-ils être exposés au propanol à la maison ?\nQuelles formations sont nécessaires pour manipuler le propanol ?\nLes fuites de propanol doivent-elles être signalées ?", "url": "https://questionsmedicales.fr/mesh/D020005?mesh_terms=Polymorphism,+Genetic&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Propanols", "description": "Quel est le traitement de l'intoxication au propanol ?\nQuand faut-il hospitaliser un patient intoxiqué au propanol ?\nY a-t-il un antidote pour le propanol ?\nComment traiter les brûlures cutanées causées par le propanol ?\nLe traitement diffère-t-il selon l'âge du patient ?", "url": "https://questionsmedicales.fr/mesh/D020005?mesh_terms=Polymorphism,+Genetic&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Propanols", "description": "Quelles complications peuvent survenir après une intoxication au propanol ?\nL'intoxication au propanol peut-elle être fatale ?\nQuels sont les risques de dépendance au propanol ?\nLes complications varient-elles selon la dose de propanol ?\nPeut-on avoir des séquelles après une intoxication au propanol ?", "url": "https://questionsmedicales.fr/mesh/D020005?mesh_terms=Polymorphism,+Genetic&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Propanols", "description": "Qui est le plus à risque d'intoxication au propanol ?\nL'âge influence-t-il le risque d'intoxication au propanol ?\nLes personnes ayant des antécédents médicaux sont-elles plus à risque ?\nLe sexe influence-t-il le risque d'intoxication ?\nLes conditions de travail affectent-elles le risque d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D020005?mesh_terms=Polymorphism,+Genetic&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication au propanol ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour mesurer les niveaux de propanol." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'exposition au propanol ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter la présence de propanol." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication au propanol ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des vertiges, des nausées, des maux de tête et des troubles de la vision." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour le propanol ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de marqueurs spécifiques, mais des niveaux élevés dans le sang peuvent indiquer une intoxication." } }, { "@type": "Question", "name": "Comment différencier le propanol des autres alcools ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests chimiques spécifiques peuvent identifier le propanol par rapport à d'autres alcools." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition au propanol ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements, des maux de tête et des vertiges." } }, { "@type": "Question", "name": "L'exposition au propanol peut-elle causer des troubles neurologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition élevée peut entraîner des troubles neurologiques temporaires ou permanents." } }, { "@type": "Question", "name": "Quels effets à long terme peut avoir le propanol ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut causer des dommages au foie et des troubles respiratoires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la voie d'exposition ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inhalation, l'ingestion ou le contact cutané peuvent provoquer des symptômes différents." } }, { "@type": "Question", "name": "Peut-on développer une allergie au propanol ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Bien que rare, des réactions allergiques cutanées peuvent survenir chez certaines personnes." } }, { "@type": "Question", "name": "Comment prévenir l'exposition au propanol ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et travailler dans des zones bien ventilées." } }, { "@type": "Question", "name": "Quelles sont les mesures de sécurité lors de la manipulation du propanol ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Porter des gants, des lunettes de protection et éviter les sources d'ignition." } }, { "@type": "Question", "name": "Les enfants peuvent-ils être exposés au propanol à la maison ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est important de stocker les produits contenant du propanol hors de portée des enfants." } }, { "@type": "Question", "name": "Quelles formations sont nécessaires pour manipuler le propanol ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des formations sur la sécurité chimique et la gestion des urgences sont recommandées." } }, { "@type": "Question", "name": "Les fuites de propanol doivent-elles être signalées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, toute fuite doit être signalée immédiatement pour éviter des accidents." } }, { "@type": "Question", "name": "Quel est le traitement de l'intoxication au propanol ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'administration de charbon actif et une surveillance médicale étroite." } }, { "@type": "Question", "name": "Quand faut-il hospitaliser un patient intoxiqué au propanol ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de niveaux élevés dans le sang." } }, { "@type": "Question", "name": "Y a-t-il un antidote pour le propanol ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour le propanol, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment traiter les brûlures cutanées causées par le propanol ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Rincer la zone touchée à l'eau et appliquer une crème apaisante pour soulager la douleur." } }, { "@type": "Question", "name": "Le traitement diffère-t-il selon l'âge du patient ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants et les personnes âgées peuvent nécessiter des ajustements dans le traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une intoxication au propanol ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des lésions hépatiques, des troubles respiratoires et neurologiques." } }, { "@type": "Question", "name": "L'intoxication au propanol peut-elle être fatale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une intoxication sévère peut entraîner la mort si elle n'est pas traitée rapidement." } }, { "@type": "Question", "name": "Quels sont les risques de dépendance au propanol ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le propanol n'est pas considéré comme une substance addictive, mais une exposition répétée peut être dangereuse." } }, { "@type": "Question", "name": "Les complications varient-elles selon la dose de propanol ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des doses plus élevées augmentent le risque de complications graves." } }, { "@type": "Question", "name": "Peut-on avoir des séquelles après une intoxication au propanol ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles neurologiques ou hépatiques peuvent persister après une intoxication." } }, { "@type": "Question", "name": "Qui est le plus à risque d'intoxication au propanol ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et ceux manipulant des solvants sont à risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'intoxication au propanol ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants et les personnes âgées sont plus vulnérables aux effets du propanol." } }, { "@type": "Question", "name": "Les personnes ayant des antécédents médicaux sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des problèmes hépatiques ou respiratoires sont plus à risque." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque d'intoxication ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent que les hommes sont souvent plus exposés, mais les femmes ne sont pas à l'abri." } }, { "@type": "Question", "name": "Les conditions de travail affectent-elles le risque d'exposition ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des environnements de travail mal ventilés augmentent le risque d'exposition au propanol." } } ] } ] }

Sources (10000 au total)

HMOX1 genetic polymorphisms and outcomes in infectious disease: A systematic review.

Heme-oxygenase 1 (HMOX1) is a critical stress response gene that catalyzes the multistep oxidation of heme. A GT(n) repeat of variable length in the promoter in has been associated with a wide range o... A search using relevant terms was performed in PubMED and EMBASE through to 15/01/21 identifying all research that studied an association between the HMOX1 GT(n) repeat polymorphism and the incidence ... 1,533 studies were identified in the search, and one via citation screening. Sixteen studies were ultimately included, seven in malaria, three in HIV, three in sepsis, and one each in pneumonia, hepat... Despite the importance of HMOX1 in survival from infection, and the association between repeat length and gene expression, the clinical data supporting an association between repeat length and inciden...

Genetic polymorphism of Y-chromosome in Kazakh populations from Southern Kazakhstan.

The Kazakhs are one of the biggest Turkic-speaking ethnic groups, controlling vast swaths of land from the Altai to the Caspian Sea. In terms of area, Kazakhstan is ranked ninth in the world. Northern... The Kazakhstan Y-chromosome Haplotype Reference Database was expanded with 468 Kazakh males from the Zhambyl and Turkestan regions of South Kazakhstan by having their 27 Y-STR loci and 23 Y-SNP marker... The Kazakhstan Y-chromosome Haplotype Reference Database was formed for 27 Y-STR loci with a total sample of 1796 samples of Kazakhs from 16 regions of Kazakhstan. The variability of the Y-chromosome ...

Association of glutathione-S-transferase polymorphism with genetic damage in paint workers.

Occupational exposure to toluene causes serious health problems ranging from drowsiness to lethal diseases such as cancer. Paint workers are exposed to toluene through inhalation or the dermal route, ... First, we included skilled paint workers (n = 30) as exposed and healthy individuals (n = 30) as control belonging to the same socio-economic strata. The genotoxicity biomarkers, Cytokinesis-block mic... A significantly higher frequency of CBMN (4.43 ± 1.50) and tail moment (TM) (11.23 ± 1.0) respectively in paint workers as compared to the control(1.50 ± 0.86 and (0.54 ± 0.37) underlined significantl... Overall, our study provides a strong rationale for identifying a clear association between glutathione-S-transferase polymorphism and genetic damage in paint workers....

Association between genetic polymorphisms and osteoarthritis development. Overview of systematic reviews.

To identify, critically evaluate and synthesize the evidence obtained from systematic reviews on the association between genetic polymorphisms and osteoarthritis (OA) development.... Considering gene polymorphisms associated with OA susceptibility (risk or protection), a comprehensive search was conducted in the following databases, without date or language restrictions: MEDLINE, ... We included 14 systematic reviews of case-control studies comparing individuals with a radiographic diagnosis of all OA types and healthy controls, all submitted to the genetic examination of differen... Based on low-quality to critically-low-quality systematic reviews, some gene polymorphisms seem to be associated with risk or protection for OA. Further high-quality studies are needed to validate the...

Genetic polymorphisms and their effects on the severity of silicosis in workers exposed to silica in Brazil.

Silicosis is a pneumoconiosis characterized by fibrosis of the lung parenchyma caused by inhalation of silica particles. Genetic factors might play a role in the severity silicosis. We sought to evalu... Nine polymorphisms were genotyped by PCR in a sample of 143 patients with silicosis in the state of Rio de Janeiro, Brazil.... Fifty-seven patients (40%) were classified as having simple silicosis and 86 (60%) were classified as having complicated silicosis. The TT genotype of rs1800469 in the TGFB1 gene showed a protective e... It appears that rs1800469 polymorphisms in the TGFB1 gene and rs763110 polymorphisms in the FASLG gene are involved in the severity of silicosis. Given the lack of studies relating genetic polymorphis...

Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy.

Many pharmacokinetic studies of lacosamide (LCM) have been reported, but no large-scale clinical study has been conducted on genetic polymorphisms that affect the metabolism of LCM. Therefore, we desi... Adult patients with epilepsy who received LCM at Seoul National University Hospital were enrolled. Blood samples were obtained from 115 patients taking LCM for more than 1 month with unchanged doses a... The serum LCM concentration showed a linear correlation with the daily dose (r = .66, p < .001). In genetic analysis, 43 patients (38.7%) were extensive metabolizers (EMs), 51 (45.9%) were intermediat... Genetic polymorphisms of the CYP2C19 gene affect the serum LCM concentration. Because efficacy and toxicity are apparently related to serum LCM levels, the genetic phenotype of CYP2C19 should be consi...